In 2023, the Waxetil workshop with an annual production capacity of 200 tons was completed and put into production; the Cefuroxime Axetil DC grade workshop with an annual production capacity of 150 tons was completed and put into production.

Titan won the title of specialized and sophisticated enterprise that produce new and unique products in Guangdong.

In 2022, a workshop with an annual production capacity of 10 tons of Flomoxef intermediate was completed and put into operation; a workshop with an annual production capacity of 20 tons of Cefditoren Pivoxil was completed and put into operation.

Titan passed review as a high-tech enterprise.

Titan won the Heyuan City Health Enterprise in 2022 and the National Intellectual Property Advantage Enterprise.

In 2021, Titan won the title of Top 500 Manufacturing Enterprises in Guangdong Province.

Won the title of Guangdong Province Doctoral Workstation (the first in Zijin County)

In 2020, Titan obtained CEP of the Cefuroxime Axetil amorphous, and the export market grew rapidly.

Established Heyuan Titan New Drug Research Institute to promote the new direction of product technology innovation and new drug development.

Won the honor of advanced collective in Heyuan City.

In 2019, Titan passed EU GMP re-certification for the third time.

Won the title of "National High-tech Enterprise" for the fourth time.

In 2018, Titan obtained CEP of Cefuroxime Sodium.

Provincial industrial technological innovation supports advanced enterprise.

Passed the evaluation of enterprise dual-chemical integration management system.

In 2017, Titan became the largest export supplier of cefuroxime APIs in China, with annual export of cefuroxime APIs exceeding 6 million US dollars.

It was awarded as a Reliable and Credible Enterprise for twenty consecutive years (1998-2017) .

Third Prize of Guangdong Provincial Science and Technology Award (Research and Application of Cefuroxime Sodium Synthesis Process Technology).

In 2016, Titan passed EU GMP re-inspection.

Titan obtained the CEP of Cefuroxime Sodium.

Titan won the title of "National High-tech Enterprise" for the third time in a row.

In 2015, in response to the call of national environmental protection legislation, the supporting optimization and transformation of sewage system was completed, and the effluent discharge indicators met the national first-class discharge standard.

Special Prize of Science and Technology Progress Award (Cefuroxime Axetil Synthesis Process Technology) in Heyuan City.

A benchmark enterprise in the pharmaceutical industry in Heyuan City.

In 2014, a 600 ton/year cefuroxime workshop was put into production, becoming the world's largest producer of Cefuroxime APIs.

National production safety standardization level-III enterprise (light industry).

In 2013, Titan passed EU GMP certification and Chinese GMP (version 2010) certification for the Cefuroxime Sodium sterile API and Cefuroxime Axetil amorphous API.

It passed the review of "National High tech Enterprise".

Four 100 demonstration projects for the integration of informatization and industrialization in Guangdong Province.

In 2012, Titan began the construction of a new workshop with an annual output of 600 tons of cefuroxime.

Heyuan City Excellence Promotion Activity - Advanced Grassroots Party Organization.

Awarded as a Reliable and Credible Enterprise for 15 consecutive years (1998-2012).

In 2011, the production capacity of freeze-dried sterile APIs was expanded to 60 tons/year.

It was recognized by Guangdong Province as a strategic emerging industry cultivation enterprise.

First Prize of Heyuan City Science and Technology Progress Award (Research on Production Technology of Cedixime API)

In 2010, it was recognized as a "National High-tech Enterprise"; the production capacity of sterile APIs was expanded to 600 tons per year, and passed GMP certification.

Second Prize of Heyuan City Science and Technology Progress Award (Innovative Technology of New Cedixime Hydrochloride).

In 2009, Titan became a qualified supplier of Ratiopharm for the Cefuroxime Sodium API, who is the largest generic drug manufacturer in Germany.

The solvent recovery workshop with an annual recovery capacity of 450,000 tons was completed and put into operation.

Annual Clean Production exemplary organization.

In 2008, the production capacity of oral API workshop was expanded to 200 tons per year.

Home of Advanced Workers in Heyuan City.

In 2007, the new office building and QC lab with an investment of RMB 10 million was completed and put into use.

Guangdong Province Pharmaceutical Production and Operation Integrity Demonstration Unit.

It was awarded as a Reliable and Credible Enterprise for ten consecutive years.

In 2006, the production capacity of sterile API production workshop was expanded to 300 tons per year.

Top 30 Growing Small and Medium-sized Industrial Enterprises in Heyuan City in 2006.

In 2004, the crystalline oral API workshop with an annual production capacity of 20 tons was put into operation.

Excellent High-tech Enterprise in Guangdong Province.

First Prize of Heyuan Science and Technology Progress Award (Technological Innovation of Cefuroxime Sodium).

In 2003, the second sterile crystalline API workshop with an annual production capacity of 80 tons was put into operation.

Cefuroxime Sodium began to be sold to the European market through the EU EDMF.

Annual Advanced Unit for Environmental Protection and Excellent Private Technology Enterprise in Heyuan City.

In 2002, it was recognized as "Guangdong High-tech Enterprise" and "Guangdong Innovative Technology Enterprise".

In 2000, the workshop for the production of Cefuroxime Acid and Cefuroxime Axetil (crystalline) was completed and put into operation.

Oral API workshop with annual production capacity of 30 tons was completed and put into operation, and passed the GMP certification of National Medical Products Administration.

Advanced unit of foreign-related industrial enterprises.

In 1999, the crystalline oral API workshop with an annual production capacity of 40 tons was put into operation.

Titan was the first domestic enterprise to obtain the approval for the production of Cefuroxime Sodium, with 6 years of administrative protection for new drugs.

Advanced Industrial Work Unit of the Year

In 1998, a freeze-dried API workshop with an annual production capacity of 50 tons was completed and put into operation.

In 1997, a Cefazolin Acid production workshop with an annual production capacity of 80 tons was completed and put into operation.

In 1996, a mountain was leveled to set up modern chemical plants.

In 1995, the company was incorporated.